Keyphrases
Ablation
23%
Academic Productivity
32%
Academic Rank
20%
Adenovirus
53%
Adenovirus Death Protein
18%
Administrative Database
16%
Breast Cancer
28%
Breast Cancer Patients
21%
Breast Cancer Treatment
26%
Breast Reconstruction
16%
Cancer Therapy
16%
Cancer Treatment
21%
Chemoradiation
23%
Chemotherapy
47%
Conditionally Replicating Adenovirus
22%
Confidence Interval
21%
Cyclooxygenase-2
16%
Cytoreductive Surgery
25%
Elective Surgery
16%
Estrogen Receptor-positive Breast Cancer
18%
Hamster Model
18%
Hepatic Metastasis
17%
Hirsch Index
32%
Human Sodium Iodide Symporter (hNIS)
19%
Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
64%
Improved Survival
18%
Interferon-α (IFN-α)
51%
Liver Resection
18%
Microwave Ablation
18%
National Institutes of Health Funding
28%
Nodal Metastasis
16%
Odds Ratio
18%
Older Women
16%
Oncolytic Adenovirus
100%
Oncolytic Viral Therapy
21%
Oncolytic Virotherapy
16%
Oncolytic Virus
41%
Overall Survival
19%
Pancreatic Cancer
91%
Pancreatic Ductal Adenocarcinoma
23%
Patient Selection
17%
Peritoneal Cancer Index
17%
Resection
17%
Single Institution
34%
Surgeons
40%
Surgical Oncology
21%
Surgical Resection
20%
Tumor
26%
United States
51%
Virus
56%
Medicine and Dentistry
Adenoviridae
39%
Adjuvant Therapy
17%
Axillary Lymph Node
16%
Breast Cancer
79%
Cancer
17%
Cancer Cell
16%
Cancer Therapy
23%
Carcinomatous Peritonitis
18%
Chemoradiotherapy
33%
Cholinesterase
16%
Clinical Trial
17%
Computer Assisted Tomography
22%
COVID-19
17%
Cytoreductive Surgery
37%
Diseases
29%
Elective Surgery
16%
Estrogen Receptor Positive Breast Cancer
17%
Gallbladder Cancer
16%
Head and Neck Squamous Cell Carcinoma
16%
Hepatectomy
20%
Hyperthermic Intraperitoneal Chemotherapy
32%
Immunotherapy
19%
Interferon
19%
Interferon Alfa
16%
Liver Injury
16%
Liver Metastasis
29%
Malignant Neoplasm
41%
Mastectomy
20%
Metastatic Carcinoma
23%
Microwave Thermotherapy
32%
Neoplasm
55%
Nodal Metastasis
16%
Oncologist
17%
Oncolytic Adenovirus
67%
Oncolytic Virotherapy
26%
Oncolytic Virus
37%
Overall Survival
32%
Paclitaxel
16%
Pancreas Adenocarcinoma
25%
Pancreas Cancer
70%
Patient Satisfaction
16%
Patient Selection
17%
Peritoneum Cancer
16%
Recurrent Disease
42%
Retroperitoneal Lymph Node Dissection
18%
Sentinel Lymph Node
16%
Surgeon
40%
Surgical Oncology
23%
Telemedicine
16%
Virus
37%